Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
3.82
0.01 (0.26%)
At close: May 14, 2025, 3:59 PM
3.84
0.52%
After-hours: May 14, 2025, 04:20 PM EDT
Contineum Therapeutics Class A Common Stock Revenue
Contineum Therapeutics Class A Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Contineum Therapeutics Class A Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
41
Market Cap
98.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|